{
    "code": "60000946",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000946",
    "time": "2020-06-12 04:03:13",
    "許可證字號": "衛部菌疫輸字第000946號",
    "註銷狀態": "已註銷",
    "註銷日期": "109\/04\/13",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "107\/09\/04",
    "發證日期": "102\/09\/04",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000094600",
    "中文品名": "克癌平 凍晶注射劑440毫克",
    "英文品名": "Herclon 440mg",
    "適應症": "Herclon應使用於下列HER2過度表現或HER2基因amplification之早期乳癌、轉移性乳癌患者\r\n\r\n說明：\r\n1.早期乳癌(EBC)：\r\n(1)經外科手術、化學療法(術前或術後)之輔助療法。\r\n(2)以doxorubicin與cyclophosphamide治療，再合併pactlitaxel或docetaxel之輔助療法。\r\n(3)與docetaxel及carboplatin併用之輔助療法。\r\n(4)術前與化學療法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)\r\n\r\n2.轉移性乳癌(MBC)：\r\n(1)單獨使用於曾接受過一次(含)以上化學療法之轉移性乳癌；除非患者不適合使用anthracyclin或taxane，否則先前之化學治療應至少包括anthracyclin或taxane。\r\n使用於荷爾蒙療法失敗之荷爾蒙受體陽性之患者，除非患者不適用荷爾蒙療法。\r\n(2)與pactlitaxel或docetaxel併用於未曾接受過化學療法之轉移性乳癌。\r\n(3)與芳香環酶抑制劑併用於荷爾蒙受體陽性之轉移性乳癌。\r\n\r\n3.轉移性胃癌(MGC)：\r\nHerclon合併capecitabine(或5-f1uorouracil)及cisplatin適用於未曾接受過化學治療之HER2過度表現轉移性胃腺癌(或胃食道接合處腺癌)的治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "每小瓶附溶劑20毫升，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TRASTUZUMAB",
    "限制項目": "",
    "申請商名稱": "1903101100  台灣羅氏醫療診斷設備股份有限公司",
    "申請商地址": "台北市中山區民權東路3段2號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0767100  GENENTECH INC.",
            "製造廠廠址": "4625 NW BROOKWOOD PARKWAY, HILLSBORO OREGON, 97124 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "製劑廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0208000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "次包裝廠"
        },
        {
            "製造廠名稱": "FUS0767000  GENENTECH, INC.",
            "製造廠廠址": "1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000500",
            "成分名稱": "TRASTUZUMAB",
            "含量描述": "",
            "含量": "440.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Herclon 440mg_HTO_中文仿單_0815-TRA-01-104-08-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000946&Seq=003&Type=9"
        },
        {
            "title": "Herclon 440mg_標籤_000946-1-STK-01-104-08-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000946&Seq=006&Type=8"
        }
    ]
}